Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 17: 851-866, 1971;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vesell, E. S.
Right arrow Articles by Passananti, G. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vesell, E. S.
Right arrow Articles by Passananti, G. T.

Clinical Chemistry, Vol 17, 851-866, Copyright © 1971 by the American Association for Clinical Chemistry

Utility of Clinical Chemical Determinations of Drug Concentrations in Biological Fluids

Elliot S. Vesell 1 and G. Thomas Passananti 1

1 Department of Pharmacology, M. S. Hershey Medical Center, The Pennsylvania State University College of Medicine, Hershey, Pa. 17033.

Iatrogenic drug toxicity has become a major medical problem. An approach to avoiding adverse reactions arising from drug accumulation is suggested and explored in depth. Large differences in the rates at which individuals metabolize several commonly used drugs are reviewed, because they illustrate the dangers of prescribing drugs solely according to body weight or surface area, and they emphasize the need for more satisfactory guidelines. Direct measurement of certain drugs in blood is suggested as a convenient, economical, and reliable solution to this problem. In healthy nonmedicated subjects, rates of decay of certain drugs are highly reproducible. In spite of large, genetically controlled differences among subjects in rates of drug metabolism, individuals do not vary significantly with respect to the pharmacological effects produced by certain well-defined blood concentrations of most drugs. For this reason, blood concentrations of most drugs may be conveniently divided into three separate ranges: the low range of therapeutic ineffectiveness; the intermediate range, in which the pharmacologic activity of the drug with negligible toxic side reactions is produced; and, finally, the toxic range. Because many potent drugs with a narrow therapeutic index are in use today—both alone and in combination—it is extremely difficult for the physician to maintain his patients consistently within the therapeutic range and outside of the ineffective or toxic range. Toxicity could be appreciably decreased if this approach of measuring drug concentrations in blood were more widely used in selecting and modifying drug dosage. Clinical advantages and limitations of measuring drug concentrations in blood, as well as the pharmacologic and genetic principles underlying them, are discussed.


Key Words: studies of twins • genetic and environmental influences on response to drugs • drug half-lives • metabolism of chemically unrelated drugs • drug interactions • control of drug action • adverse drug reactions • interindividual variation • decreasing costs of hospitalization

Submitted on April 27, 1971




The following articles in journals at HighWire Press have cited this article:


Home page
 ScienceHome page
J. L. Barker and H. Gainer
Pentobarbital: Selective Depression of Excitatory Postsynaptic Potentials
Science, November 16, 1973; 182(4113): 720 - 722.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1971 by the American Association for Clinical Chemistry.